NCT02872545

Brief Summary

The purpose is to compare percentages of myocardial segments showing attenuation in patients in forward tilted position (biker position) or 2 conventional positions (dorsal decubitus or semi sitting) at acquisition with D-SPECT camera in myocardial tomoscintigraphy. The hypothesis is that the percentage of myocardial segments with attenuation is significantly lower when acquisitions are made in forward tilted position (biker position). The secondary purpose is to restrict this analysis to 3 cardiac regions most subject to attenuation artifacts (anterior, apical and inferobasal regions).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 19, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

August 19, 2016

Status Verified

August 1, 2016

Enrollment Period

1 year

First QC Date

August 16, 2016

Last Update Submit

August 16, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of myocardial segments classified with attenuation artifact

    With infarction aspect but normal contraction kinetics in Gated-SPECT analysis. Left ventricle is divided in 17 segments according to American Heart Association.

    day 0

Secondary Outcomes (3)

  • Percentage of myocardial segments classified with attenuation artifact in anterior region

    day 0

  • Percentage of myocardial segments classified with attenuation artifact in apical region

    day 0

  • Percentage of myocardial segments classified with attenuation artifact in inferobasal region

    day 0

Study Arms (3)

forward tilted

EXPERIMENTAL

Patients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in forward tilted position

Procedure: Rest tomoscintigraphy in forward tiltedProcedure: Rest tomoscintigraphy in semi sitting positionProcedure: Rest tomoscintigraphy in dorsal decubitus position

semi sitting

OTHER

Patients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in semi sitting

Procedure: Rest tomoscintigraphy in forward tiltedProcedure: Rest tomoscintigraphy in semi sitting position

dorsal decubitus

OTHER

Patients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in dorsal decubitus

Procedure: Rest tomoscintigraphy in forward tiltedProcedure: Rest tomoscintigraphy in dorsal decubitus position

Interventions

Rest tomoscintigraphy in forward tilted position

dorsal decubitusforward tiltedsemi sitting

Rest tomoscintigraphy in forward tilted position, followed by a second rest tomoscintigraphy in semi sitting position, after max 30 min

forward tiltedsemi sitting

Rest tomoscintigraphy in forward tilted position, followed by a second rest tomoscintigraphy in semi sitting position, after max 30 min

dorsal decubitusforward tilted

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Affiliation to social security
  • Signed informed consent
  • Previous clinical examination authorizing patient to undergo tomoscintigraphy
  • Patient with abnormal results of stress tomoscintigraphy and needing a rest tomoscintigraphy
  • Patient with sinus and regular cardiac rhythm
  • Patient with stable clinical status (without signs of unstable cardiac or coronary failure, without uncontrolled hypertension under treatment)

You may not qualify if:

  • Women of childbearing potential without effective contraception
  • Evolutive pregnancy
  • Breastfeeding patient
  • Contraindication to tomoscintigraphy
  • Patient with history of hypersensibility to tomography radiotracer STAMICIS® or one of components
  • Patient in life-and-death emergency
  • Patient with history of disorders possibly interfering with contractility
  • Patient with normal results of stress tomoscintigraphy
  • Person under legal protection or incapable to consent
  • Person deprived of liberty by judicial or administrative decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Médecine Nucléaire - CHRU de Nancy-Brabois

Vandœuvre-lès-Nancy, France

RECRUITING

Study Officials

  • Mathieu PERRIN, Dr

    Service de Médecine Nucléaire - CHRU de Nancy-Brabois - Vandoeuvre Lès Nancy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mathieu PERRIN, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2016

First Posted

August 19, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

August 19, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations